Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474746 · ClinicalTrials.gov registry record · Phase 2
Trial of Sertraline to Treat Children With Fragile X Syndrome
A Phase 2 study, sponsored by Randi J. Hagerman, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT01474746 is a Phase 2 study that has completed, run by Randi J. Hagerman, MD. The registered enrollment target is 57 participants.
The verdict
NCT01474746, a Phase 2 study, has completed, sponsored by Randi J. Hagerman, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study is a control trial of sertraline (Zoloft) in fragile X syndrome children aged 2 years to 5 years 8 months old. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in language and a decrease in autistic symptoms.
Interventions
- DRUG Placebo
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474746
The ClinicalTrials.gov registry entry for NCT01474746 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Randi J. Hagerman, MD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01474746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474746 about?
NCT01474746 is a clinical study titled "Trial of Sertraline to Treat Children With Fragile X Syndrome". This study is a control trial of sertraline (Zoloft) in fragile X syndrome children aged 2 years to 5 years 8 months old. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in languag...
What is the current status of trial NCT01474746?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2012-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01474746?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT01474746?
This trial is sponsored by Randi J. Hagerman, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.